While at CBPartners, I had the opportunity to research, develop, and publish several research posters at ISPOR Europe 2020 and ISPOR Asia-Pacific 2020.
Research Posters.
-
[ISPOR Asia-Pacific 2020] Comparison of Healthcare Systems and Opportunities for Innovative Drugs Across India, Vietnam, and Indonesia
Objectives: To understand how various healthcare system archetypes in APAC markets (e.g., India, Vietnam, and Indonesia) lead to access for high-cost innovative oncology treatments.
-
[ISPOR Europe 2020] Cost Containment in the Netherlands: Lock it Down
Objectives: To understand the implementation and impact of the Netherland’s lock system on high-cost drug pricing and patient access in the oncology space.
-
[ISPOR Europe 2020] Demonstrating Payer Value for Adjuvant and Neoadjuvant Therapies
Objectives: To identify challenges associated with the HTA evaluation of neo-/adjuvant oncology therapies in major EU countries, given difficulties in demonstrating benefit in payer-preferred outcomes such as overall survival, and outlining factors that can drive favorable HTA outcomes.